DEC 27, 2016 6:52 PM PST

New Experimental Drug To Mend Heart Failure

WRITTEN BY: Kara Marker

Cimaglermin, a new drug under investigation, could be the future of cardiovascular medicine. A new study from scientists at Vanderbilt show the possibility of the drug for the restoration of cardiac function after heart failure, a leading cause of death for Americans.

Source: www.abouthf.org

More often than not, heart failure patients with severe left ventricular systolic dysfunction in particular do not respond well to current methods of treatment, which led researchers to cimaglermin as an alternative.

Led by Vanderbilt’s Daniel L. Lenihan, MD, researchers conducted a study with 40 heart failure patients who had all been receiving optimal medical therapy post-heart failure for at least three months before they entered the trial and began receiving cimaglermin. However, the researchers only examined the effects on safety and efficacy for a single dose of cimaglermin.

Compared to control participants who were just given a placebo, participants who received the single infusion of cimaglermin showed a substantial increase in pumping capacity, measured in terms of left ventricular ejection fraction. While still an experimental drug, cimaglermin was already being shown to boost the natural mechanisms for repairing all aspects of heart: structural, metabolic, and contractile elements.

“Instead of blocking the fundamental mechanisms that lead to cardiac injury, the early results with cimaglermin suggest that it may also be possible to administer therapeutics that allow the failing heart to repair itself using its own repair mechanisms,” explained Douglas L. Mann, MD, FACC, editer-in-chief of JACC: Back to Translational Science. The current study showed that the most common side effects of the drug were nausea and headaches.

“As with all experimental therapeutics, additional studies will be required and subject to regulatory review to determine if the relative risks and benefits of cimaglermin warrant approval,” said Lenihan. Studies will continue with more participants and more doses of the drug.

Lenihan’s study was recently published in the journal JACC: Basic to Translational Science.

Sources: Vanderbilt University, American College of Cardiology

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
DEC 03, 2019
Cannabis Sciences
DEC 03, 2019
Cannabis Dependence Poses Danger for Post-op Heart Attacks
People undergoing common surgeries are immediately at an increased risk for post-op heart attack and potentially stroke ...
JAN 17, 2020
Cardiology
JAN 17, 2020
Eating Walnuts Reduces Risk of Heart Disease
Walnuts may be more than just a tasty snack. Researchers from the University of Pennsylvania have found that they may al ...
MAR 20, 2020
Drug Discovery & Development
MAR 20, 2020
WHO Says Ibuprofen May Still Work Against COVID-19
Since the announcement of a French Health Minister in recent days linking usage of ibuprofen and other non-steroidal ant ...
APR 30, 2020
Cardiology
APR 30, 2020
Pregnancy Issues May be Associated with Future Heart Problems
New research presented at the American College of Cardiology Scientific Session virtual meeting found that a history of ...
MAY 21, 2020
Clinical & Molecular DX
MAY 21, 2020
Taking the Guesswork out of Fat Consumption
  When it comes to healthy eating, we often receive mixed messages. Low fat diets that have been popularized for de ...
MAY 20, 2020
Cardiology
MAY 20, 2020
Hearts Beat Differently to Music
Does some music relax you, does other music excite you? There is a physiological response to music, and your heart may b ...
Loading Comments...